• Skip to Content
  • Skip to Navigation
  • Skip to Footer
  • Skip to Cookie Settings
Wipro Logo
What We Do
What We Do
Services
Applications Artificial Intelligence Business Process Services Cloud Consulting Cybersecurity Data & Analytics Digital Experiences Engineering Sustainability
Industries
Banking & Financial Services
›
Banking Capital Markets Insurance
Comms, Media & Information Services
›
Communications Media & Info Services
Consumer
›
Consumer Packaged Goods Education Professional Services Public Sector Retail Travel, Transportation, Hospitality and Services
Energy, Manufacturing and Resources
›
Aerospace & Defense Automotive Engineering Construction Operations Industrial & Process Manufacturing Natural Resources Oil & Gas Utilities
Hi-Tech
›
Consumer Electronics Semiconductors
Technology Products and Services
›
Network & Edge Providers
Healthcare Life Sciences & Pharma Medical Devices Platforms, Software Products and Gaming
Services
Applications Artificial Intelligence Business Process Services Cloud Consulting Cybersecurity Data & Analytics Digital Experiences Engineering Sustainability
Industries
Banking & Financial Services
Banking Capital Markets Insurance
Comms, Media & Information Services
Communications Media & Info Services
Consumer
Consumer Packaged Goods Education Professional Services Public Sector Retail Travel, Transportation, Hospitality and Services
Energy, Manufacturing and Resources
Aerospace & Defense Automotive Engineering Construction Operations Industrial & Process Manufacturing Natural Resources Oil & Gas Utilities
Hi-Tech
Consumer Electronics Semiconductors
Technology Products and Services
Network & Edge Providers
Healthcare Life Sciences & Pharma Medical Devices Platforms, Software Products and Gaming
What We Think
About Wipro
About Wipro
About Us Analyst Reports Awards and Recognitions Case Studies Corporate Sustainability Events
Inclusion and Belonging Investors Leadership Locations News Partner Ecosystem
Privacy at Wipro Supplier Diversity Wipro Innovation Network Wipro Ventures Wipro Wellbeing
About Us Analyst Reports Awards and Recognitions Case Studies Corporate Sustainability Events
Inclusion and Belonging Investors Leadership Locations News Partner Ecosystem
Privacy at Wipro Supplier Diversity Wipro Innovation Network Wipro Ventures Wipro Wellbeing
Careers
Contact Us
Wipro IG Linkedin Wipro

Europe ›

Europe Sub Menu Opened
  • Benelux en
  • Europe en | de
  • Germany & Austria en | de
  • Nordic en
  • Southern Europe en | fr
  • United Kingdom & Ireland en

Americas ›

Americas Sub Menu Opened
  • Brazil en | pt
  • Canada en | fr
  • Latam en
  • Mexico en | es
  • United States en

Asia & Pacific ›

Asia & Pacific Sub Menu Opened
  • Asean en
  • Australia & New Zealand en
  • China en
  • Japan ja
  • Korea en
  • Taiwan en

India & Middle East ›

India & Middle East Sub Menu Opened
  • India en
  • Middle East en

Africa

< Business Process Services

Pharmaceutical Regulatory Affairs Strategy & Operations

favorite page unfavorite page share icon
favorite page unfavorite page

Pharmaceutical Regulatory Affairs Strategy & Operations 

Creating value in regulatory strategy and regulatory operations with intelligence and domain expertise

microsites_play_icon
X

microsites_play_icon
popup-image

Customized consulting solutions and delivery based on product, region and regulatory body to help customers take the appropriate regulatory path. 

Wipro’s regulatory expertise helps companies with strategic regulatory guidance and operational support for development of drugs as well as early and late phase commercial programs, and adopt seamlessly to the ever changing regulatory landscape.

Defining the Regulatory Strategy at Wipro

Global regulatory strategy is developed by focusing on the ecosystem comprising regulatory bodies, healthcare professionals, and patients. Wipro’s competency includes establishing regulatory strategies that span from the early drug development stage to post authorization requirements with key milestones and business objectives to achieve required regulatory outcomes. 

Our services include:

  • Regulatory intelligence services for various health authorities on submission, market authorization and post launch compliance requirements
  • ·Reviewing regulatory strategies formulated across molecules and identifying opportunities to simplify and streamline submissions for markets and/or regions
  • Interpreting and implementing health authority regulations, guidance, regulatory precedence into submission processes and publishing standards, to ensure final document content and structure are compliant with local regulatory requirements
  • Consultation and regulatory support of ad-hoc workload during MAH transfer, tech transfer or merger & acquisition (M&A)

Defining the Regulatory Operations at Wipro

The global regulatory operations function provides end-to-end visibility of regulatory compliance required for drug development, market authorization, and post approval requirements. It deals with logistics and expertise required to maintain the regulatory ecosystem, i.e., developing regulatory documents, ensuring timely submissions as per required format, coordinating with internal stakeholders, and interacting with health authorities on documents submitted for approval while ensuring compliance with all regulations in the areas where the product is marketed. 

With the health authority being the primary customer, activities performed under regulatory operations include: 

  • Authoring, preparing and reviewing  regulatory documents/dossiers - Investigational New Drug (IND), Clinical Trial Authorization (CTA), Investigational Medical Product Dossier (IMPD), New Drug Application (NDA), Abbreviated New Drug Application (ANDA), 505b(2), Marketing Authorization application (MAA), Biologics License Applications (BLAs), Drug Master File (DMF)
  • Authoring documents - Post approval study at the time of approval of premarket  approval (PMA) application
  • Gap analysis and evaluation of documents required for filing
  • Post approval changes and product lifecycle management
  • Authoring of annual reports, variations, dossier amendments, and supplements for regulatory bodies
  • CMC submission management process - Providing expertise on internal processes, electronic submission regulations and guidance regarding technical content
  • Interacting with various health authorities (FDA, EMA, PMDA, TGA, HC, etc.)  and addressing their queries, negotiations, responses
  • Literature review and surveillance
  • Communicating on regulatory issues with all stakeholders

Regulatory operations are critical for any organization and oversight on the regulatory requirements of regulatory bodies is not an option. Proper coordination with external and internal stakeholders can help to get drug products available in market(s) on time. 

© 2025 Wipro
  • Disclaimer
  • Privacy
  • Modern Slavery Statement
  • X

    Share Icon
    popup-image

    Contact Wipro

    Please fill the required details to access the content

    loading.gif